Journal of Clinical Oncology· 2015Q1
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- 2,189citations
- Q1SCImago
- 2015year
Short summary
A new Revised International Staging System (R-ISS) for multiple myeloma effectively stratifies patients into three risk groups based on existing ISS staging, chromosomal abnormalities, and lactate dehydrogenase levels.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hematology
HematologyMedicine